ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: April 2013. Rejuvenation Res, 2013; 16:158–163.
2.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2013. Rejuvenation Res, 2013; 16:245–249.
3.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2013. Rejuvenation Res, 2013; 16:333–338.
4.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2013. Rejuvenation Res, 2013; 16:427–431.
5.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2013. Rejuvenation Res, 2013; 16:529–534.
6.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: February 2014. Rejuvenation Res, 2014; 17:70–76.
7.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: June 2014. Rejuvenation Res, 2014; 17:312–317.
8.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: August 2014. Rejuvenation Res, 2014; 17:401–406.
9.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: October 2014. Rejuvenation Res, 2014; 17:468–473.
10.
ZealleyB, de GreyADNJ. Commentary on some recent theses relevant to combating aging: December 2014. Rejuvenation Res, 2014; 17:529–534.
11.
LentzMR. Apheresis of TNF and IL-2 disrupts tumour immunoevasion. Rejuvenation Res, 2013; 16:S31.
12.
ObrenovichME, EmancipatorSN, FrackeltonJP, LonsdaleD. Soluble tumor necrosis factors (sTNFR1 and sTNFR2) are increased in an age-dependent manner and in multiple organ malignancies. Rejuvenation Res, 2013; 16:S35.
13.
HoriSS, GambhirSS. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations. Sci Transl Med., 2011; 3:109ra116.
WeekesMP, TanS, PooleE, TalbotS, AntrobusR, SmithDL, GygiSP, SinclairJH, LehnerPJ. Latency-associated degradation of the MRP1 drug transporter presents a novel therapeutic target for latent human cytomegalovirus infection. Rejuvenation Res, 2013; 16:S31.
16.
CaoK, BlairCD, FaddahDA, KieckhaeferJE, OliveM, ErdosMR, NabelEG, CollinsFS. Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts. J Clin Inves, 2011; 121:2833–2844.
17.
BeliakoffG, YogalingamG, GoldinE. Treating age-related macular degeneration through enhanced lysosomal degradation of A2E. Rejuvenation Res, 2013; 16:S14.
18.
FurberJD. Inducing exocytosis to remove lipofuscin. Rejuvenation Res, 2013; 16:S21.
19.
MathieuJ, AlvarezP. Strategies for the clearance of age-related lysosomal residuals: 7-Ketocholesterol and foam cell formation. Rejuvenation Res, 2013; 16:S33.
20.
BainsW. Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age. Rejuvenation Res, 2013; 16(6):495–517.
21.
YanaiH, TacutuR, BudovskyA, CaliòA, ChilosiM, FraifeldVE. Senescent cells—bad neighbours for cancer cells?. Rejuvenation Res, 2013; 16:S44.
22.
NacevA, WeinbergIN, StepanovPY, KupferS, MairLO, UrdanetaMG, ShimojiM, FrickeST, ShapiroB. Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central target. Nano Lett., 2015; 15:359–364.
